type here...
type here...
START FREE TRIAL

Ishan Majumdar

Micron Reports in 48 Hours. The Number Everyone Is Watching Isn’t the EPS.

Technology & AI Ishan Majumdar -
Micron Technology reports earnings on Wednesday evening. The stock is up 293% so far this year. The market cap is...

AbbVie’s $11 Billion Eczema Gamble Is Bigger Than Skin

M&A Ishan Majumdar -
AbbVie Inc. (NYSE:ABBV) may be close to buying Apogee Therapeutics for about $10.9 billion in cash. That is a...

The FTC Is Coming For Amazon’s Sponsored Ads

Consumer & Retail Ishan Majumdar -
Amazon.com, Inc. (NASDAQ:AMZN) may have a new headache, and this one sits right inside something millions of shoppers see...

Moderna’s Flu Shot Won Over FDA Advisers—But Can It Win Back America?

Healthcare Ishan Majumdar -
Moderna (NASDAQ:MRNA) just landed a regulatory moment that people will argue about far beyond Wall Street. An FDA advisory...

Did Fox Pay $25 Billion For Roku’s Platform, Or Its Ad Data Edge?

M&A Ishan Majumdar -
Fox Corp (NASDAQ:FOXA) has made its biggest swing yet in streaming, agreeing to acquire Roku (NASDAQ:ROKU) in a cash-and-stock...

Nvidia Just Borrowed $25 Billion It DOESN’T NEED. That’s The Point!

Technology & AI Ishan Majumdar -
NVIDIA Corporation (NASDAQ:NVDA) just gave Wall Street a new reason to talk. The company is raising $25 billion through its...
spot_imgspot_img

Oil Crashed. Markets Are Flying. The New Fed Chair Meets Tomorrow. Don’t Get Too Comfortable.

Miscellaneous Ishan Majumdar -
Your gas was $4.07 a gallon on Sunday. That number is about to fall. Maybe to $3.50. Maybe lower. Because...

Oracle Reports Tonight. The Revenue Number Is Not The Question.

Technology & AI Ishan Majumdar -
Tonight at 5 PM ET, Oracle drops its fiscal Q4 2026 results. Wall Street expects $19.1 billion in revenue, up...

Amazon Just Paid BILLIONS For Glass. The AI Bottleneck NOBODY Is Talking About!

Consumer & Retail Ishan Majumdar -
On Monday, Amazon announced a multiyear, multibillion-dollar agreement with Corning. Corning will supply optical fiber, cable and connectivity products...

Did Ingredion Find A Mispriced Path Into Higher-Value Ingredients?

Consumer & Retail Ishan Majumdar -
Ingredion (NYSE:INGR) has moved into deal mode with a recommended all-cash offer to acquire Tate & Lyle (OTC:TATYY), valuing...

Apple’s WWDC Keynote Is Here. The Swing Factor NOBODY Is Writing About Is NOT Siri!

Technology & AI Ishan Majumdar -
Two years ago Apple showed the world a "new Siri" that barely worked. Today it gets one more chance. In...

Is SpaceX Asking $1.75 Trillion For A Company Truly Worth NO MORE THAN $780 Billion?

Technology & AI Ishan Majumdar -
The largest IPO in history just launched its roadshow. Here's what Wall Street keeps getting wrong about it. Let's start...
Load more

Baptista Research is a financial research house focused on the U.S. markets. We cover the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms.

Company

Headlines

Micron Reports in 48 Hours. The Number Everyone Is Watching Isn’t the EPS.

0
Micron Technology reports earnings on Wednesday evening. The stock is...

AbbVie’s $11 Billion Eczema Gamble Is Bigger Than Skin

0
AbbVie Inc. (NYSE:ABBV) may be close to buying Apogee...

The FTC Is Coming For Amazon’s Sponsored Ads

0
Amazon.com, Inc. (NASDAQ:AMZN) may have a new headache, and...

Moderna’s Flu Shot Won Over FDA Advisers—But Can It Win Back America?

0
Moderna (NASDAQ:MRNA) just landed a regulatory moment that people...

Newsletter

Get important news delivered directly to your inbox and stay connected!

Copyright © 2026 Baptista Research. All rights reserved.